DEUTSCHE BANK AG\ - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 75 filers reported holding ADMA BIOLOGICS INC in Q3 2021. The put-call ratio across all filers is 4.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$386,404
+25.8%
107,934
+29.7%
0.00%
Q2 2023$307,148
-29.5%
83,238
-36.8%
0.00%
Q1 2023$435,781
-34.8%
131,656
-23.6%
0.00%
Q4 2022$668,334
+68.3%
172,251
+5.5%
0.00%
Q3 2022$397,000
+14.1%
163,341
-7.1%
0.00%
Q2 2022$348,000
+123.1%
175,760
+105.8%
0.00%
Q1 2022$156,000
+30.0%
85,4000.0%0.00%
Q4 2021$120,000
+23.7%
85,4000.0%0.00%
Q3 2021$97,000
-29.2%
85,4000.0%0.00%
Q2 2021$137,000
-39.6%
85,400
-33.9%
0.00%
Q1 2021$227,000
-11.0%
129,244
-1.0%
0.00%
Q4 2020$255,000
-40.3%
130,493
-26.9%
0.00%
Q3 2020$427,000
-63.8%
178,538
-55.7%
0.00%
-100.0%
Q2 2020$1,181,000
+272.6%
403,179
+266.6%
0.00%
Q1 2020$317,000
-24.0%
109,983
+5.3%
0.00%
Q4 2019$417,000
-6.9%
104,491
+3.4%
0.00%
Q3 2019$448,000
+222.3%
101,050
+179.4%
0.00%
Q2 2019$139,000
+52.7%
36,171
+48.9%
0.00%
Q1 2019$91,000
+54.2%
24,286
-3.4%
0.00%
Q4 2018$59,000
-95.6%
25,131
-88.4%
0.00%
Q3 2018$1,346,000
+351.7%
216,922
+226.4%
0.00%
Q2 2018$298,000
+1003.7%
66,457
+1318.8%
0.00%
Q2 2016$27,000
-18.2%
4,684
+11.5%
0.00%
Q1 2016$33,000
+200.0%
4,200
+250.0%
0.00%
Q2 2015$11,0001,2000.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Aisling Capital LLC 3,608,171$8,624,0002.44%
Broadfin Capital, LLC 4,226,077$10,100,0001.33%
MORGENS WATERFALL VINTIADIS & CO INC 400,000$956,0000.85%
Consonance Capital Management LP 4,588,352$10,966,0000.81%
Perceptive Advisors 6,521,102$14,542,0000.55%
Diag Capital Management, LP 182,100$435,0000.50%
683 Capital Management, LLC 805,000$1,924,0000.12%
ARDSLEY ADVISORY PARTNERS LP 50,000$120,0000.03%
AVANTAX ADVISORY SERVICES, INC. 65,050$156,0000.03%
PURA VIDA INVESTMENTS, LLC 37,170$89,0000.02%
View complete list of ADMA BIOLOGICS INC shareholders